Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

Share Price Information for Tyman (TYMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 369.00
Bid: 369.00
Ask: 372.00
Change: 5.00 (1.37%)
Spread: 3.00 (0.813%)
Open: 381.50
High: 381.50
Low: 369.00
Prev. Close: 364.00
TYMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

14 Jan 2010 07:00

RNS Number : 5239F
Lupus Capital PLC
14 January 2010
 



Lupus Capital plc

("Lupus" or the "Company")

Board Changes: Appointment of Chief Executive Officer

Chief Executive Officer

Lupus Capital plc, the securityresidential products and marine breakaway couplings group, is pleased to announce the appointment of Louis Eperjesi to the Board as Chief Executive Officer ("CEO") with effect from 22 February 2010. Mr Eperjesi has been appointed following a comprehensive search process conducted by the Board involving independent consultants.

Mr. Eperjesi has an extensive and successful track record in the building materials and manufacturing sectors, most recently at Kingspan Group Plc, the €1.1bn market capitalisation international building products business, where he was an executive director on the main board and Divisional Managing Director of Kingspan Insulated Panels, the Group's largest division. In 2008 Kingspan Insulated Panels had sales of €590 million, operated from five manufacturing sites and had 900 employees. In the period from his appointment in 2003, Mr. Eperjesi was responsible for substantially growing sales in the division, acquiring and integrating a number of international manufacturing businesses and optimising the division's cost base. 

Prior to joining Kingspan, Mr. Eperjesi held a range of senior management positions at subsidiaries of Baxi Group Plc, Redland Plc (now part of Lafarge Group) and Caradon Plc.

Other Board Changes

In light of Mr. Eperjesi's appointment, Keith Taylor, who was appointed CEO on an interim basis on 1 July 2009, has today stood down as CEO, although he will remain on the Board for a brief transitional period. Denis Mulhall will act as CEO until 22 February 2010.

Mr. Mulhall has confirmed his intention to leave the Company following an appropriate period of handover to Mr Eperjesi.

Further announcements concerning the departure dates of Mr Taylor and Mr Mulhall from the Board will be made in due course.

Interim Management Success Fees

The Remuneration Committee has met and reviewed the performance of Mr. Taylor and Mr. Felton-Smith against the respective performance criteria agreed with them. The Remuneration Committee is satisfied that the relevant criteria have been met and accordingly Mr Taylor and Mr Felton-Smith will receive their final discretionary success fee payments of £210,000 and £120,000 respectively.

Jamie Pike, Chairman, commented:

"We are grateful to Keith for all that he has done as Chief Executive, in particular in leading the business during a very difficult period.

"I am delighted to welcome Louis to Lupus. He has an excellent track record, both across the building materials industry and in general management. Along with the recent Non-Executive appointments, I believe Lupus has a very strong Board to take the business forward."

  Enquiries

Lupus Capital plc

Jamie Pike  Tel: +44 (0)20 7976 8000

Collins Stewart Europe Limited  Tel: +44 (0)20 7523 8350

Mark Dickenson / Tom Hulme

College Hill Tel: +44 (0)20 7457 2020

Mark Garraway / Gareth David

NOTES TO EDITORS

Remuneration

Mr Eperjesi will be paid a basic salary of £300,000 per annum and will be eligible for Life Assurance, Health Cover and Permanent Health Insurance benefits. His agreement will be terminable on not less than 12 months' notice by either party. He will also be eligible to participate in corporate bonus and share option schemes. Any such schemes will be performance related and determined by the Remuneration Committee in accordance with generally accepted practice.

Share Purchase

Mr Eperjesi has confirmed that he intends to acquire shares in the Company on the basis of being a long-term shareholder.

Further information required by Rule 17 and Schedule 2(g) of the AIM Rules for Companies

Louis Leslie Alexander Eperjesi (age 47) 

Present directorships and/or partnerships:

None

Former directorships and/or partnerships (within the last five years):

Kingspan Group plc

Alsteel Fabrications Limited

Bansar Limited

Ever 2479 Limited

Interlink Fabrications Limited

Kingspan China Limited

Kingspan Controlled Environments Limited

Kingspan Door Components S.A.

Kingspan Holding N.V.

Kingspan Holdings (Panels) Limited

Kingspan Insulated Panels Pty Limited

Kingspan Limited (Irl)

Kingspan Limited (UK)

Kingspan N.V.

Saferidge Limited

Ward Insulated Panels Limited

At the date of this announcement, Mr. Eperjesi does not own any ordinary shares in Lupus.

No further disclosures are required under Schedule 2(g) of the AIM Rules for Companies.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABIGDBLSBBGGX
Date   Source Headline
6th May 20217:00 amRNSTrading Update
5th May 20217:00 amRNSDirector/PDMR Shareholding
30th Apr 20218:23 amRNSHolding(s) in Company
23rd Apr 202112:31 pmRNSNotice of Capital Markets Day
16th Apr 20219:56 amRNSNotice of AGM
9th Apr 20216:14 pmRNSHolding(s) in Company
23rd Mar 202110:59 amRNSHolding(s) in Company
22nd Mar 20213:57 pmRNSHolding(s) in Company
19th Mar 20213:05 pmRNSHolding(s) in Company
4th Mar 202111:36 amRNSDividend Declaration
4th Mar 20217:00 amRNSFinal Results
30th Dec 20209:45 amRNSDirector/PDMR Shareholding - Replacement
24th Dec 20209:45 amRNSDirector/PDMR Shareholding
10th Dec 20202:56 pmRNSHolding(s) in Company
8th Dec 20207:00 amRNSTrading Statement
2nd Nov 20206:12 pmRNSTotal Voting Rights
29th Oct 20206:04 pmRNSHolding(s) in Company
26th Oct 20204:05 pmRNSHolding(s) in Company
7th Oct 20207:00 amRNSTrading and COVID-19 Update
5th Oct 20205:45 pmRNSHolding(s) in Company
1st Oct 20204:00 pmRNSDirector/PDMR Shareholding
1st Oct 20204:00 pmRNSDirector/PDMR Shareholding
17th Sep 20207:00 amRNSDirectorate Changes
28th Aug 20204:20 pmRNSHolding(s) in Company
28th Aug 20204:20 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSHolding(s) in Company
4th Aug 20207:00 amRNSHolding(s) in Company
29th Jul 20205:00 pmRNSHolding(s) in Company
29th Jul 20205:00 pmRNSHolding(s) in Company
28th Jul 20207:00 amRNSHalf-year Report
27th Jul 20202:03 pmRNSHolding(s) in Company
27th Jul 20202:02 pmRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
21st May 20203:30 pmRNSHolding(s) in Company
20th May 202010:40 amRNSResult of AGM
20th May 20207:00 amRNSAnnual General Meeting Trading and COVID-19 Update
4th May 20204:14 pmRNSDirector/PDMR Shareholding
17th Apr 20202:33 pmRNSHolding(s) in Company
8th Apr 20207:00 amRNSNotice of AGM
3rd Apr 20203:07 pmRNSDirector/PDMR Shareholding
3rd Apr 20207:00 amRNSCOVID-19 and Dividend Update
26th Mar 20207:00 amRNSDirector/PDMR Shareholding
20th Mar 20204:31 pmRNSDirector/PDMR Shareholding
17th Mar 20204:37 pmRNSPrice Monitoring Extension
10th Mar 202011:46 amRNSHolding(s) in Company
6th Mar 20205:28 pmRNSHolding(s) in Company
5th Mar 202012:23 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFinal Results
23rd Jan 202011:49 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.